The production of new lymphatic vessels by the tumour is a key step in the promotion of cancer metastasis and COX-2 inhibitors have been shown to have antimetastatic activity in a metastatic mouse model (Roche-Nagle et al, 2004). Here, PTGS2 is linked to cancer.